2014 Help me understand this report
Intraurethral alprostadil in the management of erectile dysfunction: a reappraisal of the clinical evidence
Search citation statements
Paper Sections
Select...
1
Citation Types
0
1
0
Year Published
2014
2014
Publication Types
Select...
1
Relationship
1
0
Authors
Journals
Cited by 1 publication
(1 citation statement)
References 61 publications
0
1
0
“…As reviewed elsewhere [20,28], the efficacy and tolerability of intraurethral alprostadil (125-1000 µg) has been demonstrated in numerous clinical trials in patients with ED, as monotherapy [21, or in combination with other pharmacological agents [54][55][56][57].…”
Section: Pde5 Inhibitors: Failures and Contraindicationsmentioning
confidence: 99%
“…As reviewed elsewhere [20,28], the efficacy and tolerability of intraurethral alprostadil (125-1000 µg) has been demonstrated in numerous clinical trials in patients with ED, as monotherapy [21, or in combination with other pharmacological agents [54][55][56][57].…”
Section: Pde5 Inhibitors: Failures and Contraindicationsmentioning
confidence: 99%
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
